US$ 25.08
glp-1 agonists for type 2 diabetes Trends in the Development of Receptor Clinical Focus on GLP-1 Agonists
Description
Chen MC, Ling MH, Lai KY, Pramudityo E

CuthbertsonDJIrwinAGardnerCJDaousiCPurewalTFurlongNet al

[25] Mechanism of action [edit] Dulaglutide binds to glucagon-like peptide 1 receptors, slowing gastric emptying and increasing insulin secretion by pancreatic Beta cells

If a health product covers GLP-1s, the insurer should consider means to ensure proper utilization by clearly outlining coverage and, where applicable, prior-authorization criteria
